Paper - WANFANG MED ONLINE

You Position: Home > Paper

西洛他唑治疗血管成型术后再狭窄的分子生物学机制

( views:186, downloads:21 )

Author:: No author available

Journal Title:: GUANGDONG MEDICAL JOURNAL

Issue:: 17

DOI:: 10.3969/j.issn.1001-9448.2010.17.060

Key Word:: No keyword available

Abstract： @@ 自70年代末Gruentzig成功地进行首例人体经皮腔内冠状动脉成形术(PTCA)以来,介入性治疗已成为冠心病治疗的有效手段之一,但因其对血管壁的机械性损伤,在改善局部血流的同时,也导致一系列并发症(如急性血管闭塞、再狭窄等)而影响其临床疗效,大约有30%～50%的患者在PTCA后6个月内发生再狭窄.

Reference

[1]刘占军,徐耕.Cilostazol与经皮冠状动脉介入术后再狭窄的防治[J].2006,(3).
[2].西洛他唑对家兔血管成形术后内膜增殖和血管重构的影响[J].2005,(5).
[3]李晓英,王兆宏,刘国英,等.西洛他唑对急性冠状动脉综合症患者炎症因子及血脂水平的影响[J].2007,(10).
[4]王哲,赵家军,高聆,等.西洛他唑对糖尿病大鼠黏附分子的影响[J].2002,(11).
[5]王绽菲,张子新,曾定尹,等.抗血小板制剂对家兔血管成形术后基质金属蛋白酶及其抑制剂表达的影响[J].2004,(6).
[6]韩雅玲,王守力,李毅,等.西洛他唑对冠状动脉支架术后长期临床疗效的影响[J].2005,(z1).
[7]梁海峰,侯亚利,刘新华.西洛他唑对冠心病合并2型糖尿病患者脂代谢的影响[J].2008,(10).
[8]M B, Elam,J, Heckman,J R, Crouse,etc.Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication.[J].1998,18(12).
[9]Shibata M,Takeyama Y,Nakatani M,etc.Mechanisms of restenosis after coronary intervention. Difference between plain old balloon angioplasty and stenting.[J].2003,12(1).
[10]Dalainas I.Cilostazol in the management of vascular disease.[J].2007,26(1).
[11]K, Hayashi,S, Nakamura,R, Morishita,etc.In vivo transfer of human hepatocyte growth factor gene accelerates re-endothelialization and inhibits neointimal formation after balloon injury in rat model.[J].2000,7(19).
[12]R, Morishita,G H, Gibbons,K E, Ellison,etc.Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.[J].1993,90(18).
[13]Kariyazono H,Yamada K,Yamaguchi T,etc.Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol.[J].2001,101(6).
[14]Trevi GP,Anselmino M,Lotrionte M,etc.Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention.[J].2008,155(6).
[15]Kobayashi T,Ishida K,Kamata K,etc.Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats.[J].2008,599(1).
[16]M, Otsuki,H, Saito,X, Xu,etc.Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence.[J].2001,158(1).
[17]T, Tani,K, Uehara,T, Sudo,etc.Cilostazol, a selective type III phosphodiesterase inhibitor, decreases triglyceride and increases HDL cholesterol levels by increasing lipoprotein lipase activity in rats.[J].2000,152(2).
[18]Tsuchiya K,Niwa Y,Nakaya Y,etc.Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta.[J].2001,69(15).
[19]M, Aoki,R, Morishita,S, Hayashi,etc.Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model.[J].2001,44(8).
[20]Chi Dae Kim,Yong-Geun Kwak,Won Suk Lee,etc.Cilostazol Prevents Tumor Necrosis Factor-alpha-Induced Cell Death by Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/Cyclic AMP Response Element-Binding Protein Phosphorylation[J].2003,306(3).
[21]T M, Lee,S F, Su,C H, Tsai,etc.Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.[J].2001,101(3).
[22]Akimoto T.,Kusano E.,Asano Y.,etc.Cilostazol enhances IL-1 beta-induced NO production and apoptosis in rat vascular smooth muscle via PKA-dependent pathway[J].2002,14(7).
[23]S, Takahashi,K, Oida,R, Fujiwara,etc.Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.[J].1992,20(6).
[24]John S, Douglas,William S, Weintraub,David, Holmes.Rationale and design of the randomized, multicenter, cilostazol for RESTenosis (CREST) trial.[J].2003,26(10).
[25]Ó. G. BJÖRNSSON,J. D. SPARKS,C. E. SPARKS,etc.Regulation of VLDL secretion in primary culture of rat hepatocytes: involvement of cAMP and cAMP-dependent protein kinases[J].1994,24(2).
[26]Kambayashi J,Liu Y,Shakur Y,etc.Cilostazol as a unique antithrombotic agent.[J].2003,9(28).
[27]So Youn, Park,Jeong Hyun, Lee,Yong Ki, Kim,etc.Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor a[J].2005,312(3).
[28]B M, Hokland,J P, Slotte,E L, Bierman,etc.Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells.[J].1993,268(34).
[29]Lee HJ,Lee KM,Kim M.Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.[J].2009,207(2).
[30]Lee KU,Kim SY,Lee IK,etc.Cilostazol inhibits vascular smooth muscle cell growth by downregulation of the transcription factor E2F.[J].2005,45(4).
[31]John S, Douglas,David R, Holmes,Dean J, Kereiakes,etc.Coronary stent restenosis in patients treated with cilostazol.[J].2005,112(18).
[32]Tetsuo Morita,Toshio Motoyashiki,Hiroshi Ueki.Involvement of the Rapid Increase in cAMP Content in the Vanadate-Stimulated Release of Lipoprotein Lipase Activity from Rat Fat Pads[J].1996,19(11).
[33]A, Kibos,A, Campeanu,I, Tintoiu.Pathophysiology of coronary artery in-stent restenosis.[J].2007,9(2).
[34]Daisuke, Mori,Hideto, Ishii,Chiari, Kojima,etc.Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP.[J].2007,14(5).
[35]Bornfeldt KE,Rybalkin SD.Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.[J].1999,82(2).
[36]Farooq MM,Huang D,Gelabert HA,etc.Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation.[J].2003,114(2).
[37]Matsushita H,Nakamura T,Ogihara T,etc.Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21.[J].2000,35(1 Pt.2).
[38]Nishimoto M,rt.osaka-med.ac.jp,Kirimura K,etc.Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin II-forming enzymes.[J].2001,411(3).
[39]Jong-Hoon, Lim,Jae-Suk, Woo,Yung-Woo, Shin.Cilostazol protects endothelial cells against lipopolysaccharide-induced apoptosis through ERK1/2- and P38 MAPK-dependent pathways.[J].2009,24(2).